Cargando…

Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis

Multiple myeloma (MM) is considered to be the second most common blood malignancy and it is characterized by abnormal proliferation and an accumulation of malignant plasma cells in the bone marrow. Although the currently utilized markers in the diagnosis and assessment of MM are showing promising re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soliman, Amro M., Das, Srijit, Teoh, Seong Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305153/ https://www.ncbi.nlm.nih.gov/pubmed/34299097 http://dx.doi.org/10.3390/ijms22147470

Ejemplares similares

Role of microRNAs in Diagnosis, Prognosis and Management of Multiple Myeloma
por: Soliman, Amro M., et al.
Publicado: (2020)

Role of MicroRNA in Proliferation Phase of Wound Healing
por: Soliman, Amro M., et al.
Publicado: (2018)

Oxidative Stress in Oral Diseases: Understanding Its Relation with Other Systemic Diseases
por: Kumar, Jaya, et al.
Publicado: (2017)

Developing next generation immunomodulatory drugs and their combinations in multiple myeloma
por: Thakurta, Anjan, et al.
Publicado: (2021)

Toxicity management strategies for next-generation novel therapeutics in multiple myeloma
por: Steinbach, Mary, et al.
Publicado: (2022)

Multiple Myeloma: Challenges Encountered and Future Options for Better Treatment
por: Das, Srijit, et al.
Publicado: (2022)

Pros and Cons for Fluorescent in Situ Hybridization, Karyotyping and Next Generation Sequencing for Diagnosis and Follow-up of Multiple Myeloma
por: Ikbal Atli, E, et al.
Publicado: (2021)

Circular RNA as a Novel Biomarker for Diagnosis and Prognosis and Potential Therapeutic Targets in Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2022)

Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma
por: Yao, Qiumei, et al.
Publicado: (2019)

Next-Generation Sequencing for Clinical Management of Multiple Myeloma: Ready for Prime Time?
por: Bolli, Niccolo, et al.
Publicado: (2020)

Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
por: Medina, Alejandro, et al.
Publicado: (2020)

Proteasome inhibitors – molecular basis and current perspectives in multiple myeloma
por: Kubiczkova, Lenka, et al.
Publicado: (2014)

Tracking Clonal Evolution of Multiple Myeloma Using Targeted Next-Generation DNA Sequencing
por: Salomon-Perzyński, Aleksander, et al.
Publicado: (2022)

Dietary Acrylamide and the Risks of Developing Cancer: Facts to Ponder
por: Kumar, Jaya, et al.
Publicado: (2018)

Monitoring multiple myeloma by next-generation sequencing of V(D)J rearrangements from circulating myeloma cells and cell-free myeloma DNA
por: Oberle, Anna, et al.
Publicado: (2017)

Molecular diagnostics of a single drug-resistant multiple myeloma case using targeted next-generation sequencing
por: Ikeda, Hiroshi, et al.
Publicado: (2015)

Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
por: Flores-Montero, J, et al.
Publicado: (2017)

“Friends and foes” of multiple myeloma measurable/minimal residual disease evaluation by next generation flow
por: Pacelli, Paola, et al.
Publicado: (2022)

Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)
por: Sanoja-Flores, L., et al.
Publicado: (2018)

Recent advances in understanding multiple myeloma
por: Dhakal, Binod, et al.
Publicado: (2016)

Next-Generation Sequencing Improves Diagnosis, Prognosis and Clinical Management of Myeloid Neoplasms
por: Carbonell, Diego, et al.
Publicado: (2019)

Clinical characteristics and prognosis of multiple myeloma with bone-related extramedullary disease at diagnosis
por: Tian, Chen, et al.
Publicado: (2018)

Recent Progress of Exosomes in Multiple Myeloma: Pathogenesis, Diagnosis, Prognosis and Therapeutic Strategies
por: Wang, Xi, et al.
Publicado: (2021)

Next-Generation Biomarkers for Cholangiocarcinoma
por: Rodrigues, Pedro M., et al.
Publicado: (2021)

Clinical Utility of Next-Generation Flow-Based Minimal Residual Disease Assessment in Patients with Multiple Myeloma
por: Kim, Hyun-Young, et al.
Publicado: (2022)

The Utility of Next-Generation Sequencing for Identifying the Genetic Basis of Dementia
por: Klimkowicz-Mrowiec, Aleksandra, et al.
Publicado: (2021)

Molecular basis and diagnosis of thalassemia
por: Lee, Jee-Soo, et al.
Publicado: (2021)

Effect of Piper sarmentosum Extract on the Cardiovascular System of Diabetic Sprague-Dawley Rats: Electron Microscopic Study
por: Thent, Zar Chi, et al.
Publicado: (2012)

The Clinical Diagnosis of Multiple Myeloma
por: Ainley, N. J.
Publicado: (1954)

Diagnosis and therapy of multiple myeloma
por: Palumbo, Antonio, et al.
Publicado: (2013)

Multiple Myeloma Cell-Derived Exosomes: Implications on Tumorigenesis, Diagnosis, Prognosis and Therapeutic Strategies
por: Allegra, Alessandro, et al.
Publicado: (2021)

Machine Learning and Deep Learning Applications in Multiple Myeloma Diagnosis, Prognosis, and Treatment Selection
por: Allegra, Alessandro, et al.
Publicado: (2022)

Recent Advances in the Understanding and Treatment of Multiple Myeloma
por: Cook, Richard, et al.
Publicado: (2008)

Immunoglobulin gene rearrangement in Koreans with multiple myeloma: Clonality assessment and repertoire analysis using next-generation sequencing
por: Kim, Miyoung, et al.
Publicado: (2021)

Minimal residual disease detection by next-generation sequencing in multiple myeloma: Promise and challenges for response-adapted therapy
por: Ferla, Valeria, et al.
Publicado: (2022)

A Journey through the Inter-Cellular Interactions in the Bone Marrow in Multiple Myeloma: Implications for the Next Generation of Treatments
por: Hervás-Salcedo, Rosario, et al.
Publicado: (2022)

Next generation sequencing for molecular diagnosis of neuromuscular diseases
por: Vasli, Nasim, et al.
Publicado: (2012)

Next-Generation Sequencing-Based Molecular Diagnosis of Choroideremia
por: Shimizu, Kayo, et al.
Publicado: (2015)

A case of Multiple Myeloma with lung plasmacytoma
por: Saidi, Imane, et al.
Publicado: (2022)

Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma
por: Manzoni, Martina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0gu6af9qt6na24jqf17pjdbm5g